Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy
2021 · Journal of Clinical Oncology · 294 citations
https://doi.org/10.1200/jco.20.02015
K
Kate Absolom
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
114
Papers
3.0K
Citations
27
h-index
55
i10-index
Kate Absolom is an academic researcher from University of Leeds. The author has contributed to research in topics: Cancer survivorship and care & Childhood Cancer Survivors' Quality of Life & Palliative Care and End-of-Life Issues. The author has an h-index of 27, co-authored 97 publications.
ORCID: 0000-0002-5477-6643Papers by this author
worksProceedings of Patient Reported Outcome Measure’s (PROMs) Conference Sheffield 2016: advances in patient reported outcomes research
2016 · Health and Quality of Life Outcomes · 152 citations
https://doi.org/10.1186/s12955-016-0540-5
Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment
2017 · Annals of Oncology · 131 citations
https://doi.org/10.1093/annonc/mdx317
Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery
2019 · BMC Cancer · 75 citations
https://doi.org/10.1186/s12885-019-5657-6
Follow-up care for cancer survivors: views of the younger adult
2009 · British Journal of Cancer · 70 citations
https://doi.org/10.1038/sj.bjc.6605213
Follow-up care for cancer survivors: the views of clinicians
2009 · British Journal of Cancer · 68 citations
https://doi.org/10.1038/sj.bjc.6605160
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat